China Medical Technologies, Inc. (中国医疗技术公司) reported another quarter of strong numbers. In its Q3 (ended December 31, 2008), China Medical’s revenues from continuing operations climbed 51% to 225 million RMB ($33.0 million) and non-GAAP net income was an amazing 95% higher at 119 million RMB ($17.5 million). That’s the snapshot, but the non-GAAP numbers exclude two significant one-time events: a one-time gain from its legacy HIFU (High Intensity Focused Ultrasound) business, and a one-time charge for acquired in-process research and development costs. More details...

Stock Symbol: (NSDQ: CMED)